openPR Logo
Press release

Investigation for Investors in NASDAQ: APYX shares over potential Securities Laws Violations by Apyx Medical Corporation

04-02-2020 02:38 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Apyx Medical Corporation (NASDAQ: APYX) shares over potential securities laws violations by Apyx

An investigation for investors in Apyx Medical Corporation (NASDAQ: APYX) shares over potential securities laws violations by Apyx

An investigation was announced on behalf of investors of Apyx Medical Corporation (NASDAQ: APYX) shares over potential securities laws violations by Apyx Medical Corporation.

Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Apyx Medical Corporation (NASDAQ: APYX regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Clearwater, FL based Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. Apyx Medical Corporation reported that its annual Total Revenue rose from $16.68 million in 2018 to $28.15 million in 2019 and that its Net Income of $64 million in 2018 declined to a Net Loss of $19.65 million in 2019.

On March 16, 2020, Apyx Medical Corporation announced that its financial statements for the twelve months ended December, 31 2018 and the quarterly statements for the three and nine months ended September 30, 2018 and three months ended March 31, 2019 could no longer be relied upon and would need to be restated.

Shares of Apyx Medical Corporation (APYX) declined from $8.56 per share on January 3, 2020, to as low as $2.92 per share on March 23, 2020.

Those who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors in NASDAQ: APYX shares over potential Securities Laws Violations by Apyx Medical Corporation here

News-ID: 1995674 • Views: 257

More Releases from Shareholders Foundation

ProShares Ultra Bloomberg Crude Oil (NYSEArca: UCO) Investor Alert: Deadline in …
A deadline is coming up on September 28, 2020 in the lawsuit filed for certain investors of ProShares Ultra Bloomberg Crude Oil (NYSEArca: UCO) over alleged securities laws violations. Investors who purchased shares of ProShares Ultra Bloomberg Crude Oil (NYSEArca: UCO) have certain options and there are strict and short deadlines running. Deadline: September 28, 2020. NYSEArca: UCO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Investigation announced for Long-Term Investors in shares of Forescout Technolog …
An investigation was announced for long-term investors in shares of Forescout Technologies, Inc. (NASDAQ: FSCT) concerning potential breaches of fiduciary duties by certain directors and officers of Forescout Technologies, Inc.. Investors who are current long term investors in Forescout Technologies, Inc. (NASDAQ: FSCT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for investors in NASDAQ:
Investigation announced for Long-Term Investors in shares of Hebron Technology C …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Hebron Technology Co., Ltd.. Investors who are current long term investors in Hebron Technology Co., Ltd. (NASDAQ: HEBT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: HEBT stocks follows a lawsuit filed against Hebron
Investigation announced for Investors in shares of CrossFirst Bankshares, Inc. ( …
An investigation was announced concerning potential securities laws violations by CrossFirst Bankshares, Inc. in connection with certain financial statements. Investors who purchased shares of CrossFirst Bankshares, Inc. (NASDAQ: CFB), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether certain statements by CrossFirst Bankshares, Inc. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Apyx

Aesthetic Devices - Medical Devices Pipeline Assessment, 2019 |Key players Cuter …
A new research document is added in HTF MI database of 265 pages, titled as 'Aesthetic Devices - Medical Devices Pipeline Assessment, 2019' with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes important players/vendors such as Biosculpture Technology, BioTime, Bioxis Pharmaceuticals, BMG Pharma srl, Bmi Korea Co Ltd, Celltrix AB, CollPlant Holdings Ltd, Cutera Inc, Cynosure Inc, Cytrellis Biosystems Inc, Eclipse Aesthetics
Growth Opportunities : Aesthetic Laser-Medical Devices Pipeline Assessment, 2019 …
Albany, NY, 26th March : Recent research and the current scenario as well as future market potential of "Aesthetic Laser-Medical Devices Pipeline Assessment, 2019" globally. GlobalData's Medical Devices sector report, Aesthetic Laser - Medical Devices Pipeline Assessment, 2019" provides an overview of Aesthetic Laser currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major
Aesthetic Devices-Medical Devices Pipeline Assessment, Experiments, Market Statu …
This research study added to the broad database of Market Research Hub (MRH) focusing on the Aesthetic Devices-Medical Devices Pipeline Assessment, 2019 delivers an in-depth outlook to present information about executive summary and key performance indicators. Furthermore, readers can gather knowledge about the economic status, demographics and competitive landscape which is prevailing in the concerned industry during the review period, 2019. Overall, the purpose of this assessment is to present